NORTH CHICAGO, Ill., Feb. 13, 2025 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE:ABBV) today declared a quarterly cash dividend of $1.64 per share.

The cash dividend is payable May 15, 2025, to stockholders of record at the close of business on April 15, 2025.

Since the company's inception in 2013, AbbVie has increased its dividend by 310 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

Media:

Gabby Tarbert

(224) 244-0111

Investors:

Liz Shea

(847) 935-2211

gabrielle.tarbert@abbvie.com

liz.shea@abbvie.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302376276.html

SOURCE AbbVie